DOI: https://doi.org/10.22263/2312-4156.2026.3.82
M.O. Rusetskaya1, V.L. Kozhar2, M.A. Al Youssef1
Choosing a treatment method for breast cysts
1LLC Medical On Group – Balashikha, Balashikha, Russian Federation
2Vitebsk State Order of Peoples’ Friendship Medical University, Vitebsk, Republic of Belarus
Vestnik VGMU. 2026;25(3):82-87.
Abstract.
Objectives. To analyze the results of various methods of treating breast cysts and determine the optimal tactics for patients’ management.
Material and Methods. The treatment outcomes of 284 patients with fibrocystic breast disease were studied at Medical On Group-Balashikha (Russian Federation) and Vitebsk Regional Clinical Dispensary (Republic of Belarus). Clinical, laboratory, and instrumental data were analyzed, as well as the effectiveness of conservative, surgical, and combined treatment methods for breast cysts.
Results. A comprehensive approach to treating fibrocystic breast disease has been established to be optimal. Conservative therapy is effective for thin-walled cysts up to 1 mm in size. A combination of conservative therapy and puncture of the cyst is the treatment of choice for cysts 1-2 cm in size and with a wall thickness of up to 1 mm. Sclerotherapy has also been proven to be effective. Sectoral mammary resection is preferred for the treatment of chronic breast cysts. Laser vaporization of cysts has no advantages over other treatment methods.
Conclusions. Combination therapy allows for the most complete treatment of cystic mastopathy. Puncture and injection of a sclerosant into the cyst cavity is the most effective treatment for thin-walled lesions with the wall thickness of approximately 1 mm.
Keywords: breast cyst, cyst puncture, conservative therapy, sclerotherapy, surgical treatment.
References
1. Muzheynek EL, Kiseleva VI, Rozhkova NI, Ashrafyan LA. Between mastopathy and breast cancer: risk factors and pathogenetic treatment. Moscow, RF: GEOTAR-Media; 2024. 336 р. (In Russ.).
2. Petrov YuA, Tarasova AYu, Palieva NV, Bibyaeva EYu. Psychological and gynecological health of women with benign breast diseases. Glavnyi Vrach Yuga Rossii. 2025;(1):31-33. (In Russ.).
3. Kononenko TS, Karakhalis LYu, Penzhoyan GA. Breast dysplasia in the gynecology practice. Akusherstvo i Ginekologiya: Novosti, Mneniya, Obuchenie. 2025;13(1):123-130. (In Russ.). doi: http://dx.doi.org/10.33029/2303-9698-2025-13-1-123-130
4. Kogan IYu, Musina EV. Mastopathy in gynecological practice: ruk dlya vrachei. Moscow, RF: GEOTAR-Media; 2021. 303 р. (In Russ.). doi: http://dx.doi.org/10.33029/9704-6225-6-MAS-2021-1-304
5. Arabachyan MI, Solovyev VI, Borsukov AV. The evolution of cystic mastopathy treatment. Vestnik Smolenskii Gosudarstvennoi Meditsinskoi Akademii. 2018;17(4):151-156. (In Russ.).
6. Arabachyan MI, Solovyev VI, Borsukov AV. Minimally invasive technologies in the treatment of cystic mastopathy under ultrasound navigation. Research'n Ppractical Medicine Journal. 2019;6(spetsvyp):46. (In Russ.).
7. Tishchenko MG. Megalopolis syndrome. Current relevance. Scientist. 2022;(4):181-184. (In Russ.).
8. Andreeva EN, Sheremetyeva EV. Irregular menstrual cycle in women of reproductive age as part of metropolitan syndrome. Ginekologiya. 2020;22(6):6-10. (In Russ.).
Submitted 09.03.2026
Accepted 19.06.2026
Information about authors:
Marina O. Rusetskaya– Candidate of Medical Sciences, mammologist, LLC Medical On Group – Balashikha, Russian Federation, e-mail: Этот адрес электронной почты защищён от спам-ботов. У вас должен быть включен JavaScript для просмотра.;
V.L. Kozhar – Candidate of Medical Sciences, associate professor of the Chair of Oncology with the course of the Faculty for Advanced Training & Retraining, Vitebsk State Order of Peoples’ Friendship Medical University;
M.A. Al Youssef – oncologist, LLC Medical On Group – Balashikha, Russian Federation.
